Jefferies upgraded Aurinia Pharmaceuticals (AUPH) to Buy from Hold with a price target of $21, up from $10. The company’s commercial performance ...
18hOpinion
The FDA’s Meltdown Escalates
An ethics complaint leads to a resignation, and the agency shifts approval standards.
Investor's Business Daily on MSN
Viridian Therapeutics Scores Relative Strength Rating Upgrade
Viridian Therapeutics VRDN saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback